Early in 2014, a report published in the Lancet put that “Emerging infectious diseases are an important public health threat and infections with pandemic potential are a major global risk. A need exists to develop trust and effective meaningful collaboration between countries to help with rapid detection of potential pandemic infections and initiate public health actions.”
Here in 2024, infectious diseases are, again and again, dominating the global agenda. Having experienced the shifting and mixing bombardment, more and more people realized the importance of detection, calling for more effective collaboration in diagnostic solution development. International exhibitions like Medlab Middle East 2024 serve as critical platforms for showcasing advancements in infection diagnostics and treatment.
Table of Contents
Medlab 2024 – A Platform for Progress
International exhibitions play a crucial role in showcasing the potential of infection diagnostics and treatment solutions by providing a global platform for sharing innovative technologies, fostering collaboration among experts, and facilitating the dissemination of cutting-edge research, ultimately advancing the field of healthcare on a global scale.
Medlab 2024, a cornerstone in this arena, took place from February 5th to 8th, 2024, at the prestigious Dubai World Trade Centre in Dubai, UAE. Nestled in the heart of this vibrant city, the event promises a convergence of cutting-edge advancements, bringing together the brightest minds and innovators in the field of diagnostics.
Sansure at Medlab 2024 – the Potential of In Vitro Diagnostic Solutions for the Future Infection Diagnostics
The theme of Medlab 2024 is aimed at paving the way for technological advancements and sustainability in laboratory medicine. Attendees can expect to explore a dynamic landscape of emerging technologies, breakthrough discoveries, and revolutionary solutions that are reshaping the future of healthcare. Sansure, with the commitment that is compliant with the expectation of Medlab 2024, brought out their latest result in infection diagnostic solutions.
- iPonatic III
The compact powerhouse is a game-changer, bridging the gap between molecular diagnostics and patients. The latest POCT solution streamlines the sample processing, testing, and data analysis, trying to hit the target of “sample-in, result-out.” Nowadays, it is widely applied for STI, HPV, RTI, and other infection detection.
- Surelite Automated CLIA System
As the spotlight shifts, the Surelite series emerges as a beacon of innovation in automated Chemiluminescence Immunoassay (CLIA) systems.
Surelite 8 and Surelite 16 stand as compact, automated CLIA systems, proficiently furnishing swift and precise diagnostic results in a mere 15 minutes. Their intelligent design, characterized by an all-in-one cartridge and an extensive range of assays, adeptly caters to diverse clinical requirements without necessitating additional consumables, ensuring minimal waste in the process.
- Automated Nucleic Acid Extraction System
For those seeking pioneering solution in automated nucleic acid extraction., the Natch series unfolds, featuring the Natch 48 and Natch CS2 – automated nucleic acid extraction systems. These systems are renowned for their high throughput, high precision, and top-efficiency capabilities. The system ensures a faultless workflow for sample preprocessing and nucleic acid extraction. Their emphasis on high-throughput processing makes them particularly suitable for applications requiring large-scale sample handling, establishing the solution as a reliable and innovative choice for optimizing nucleic acid extraction workflows.
- Automated Electrochemiluminescence Analyzer
The YnY 2050 analyzers represent cutting-edge, fully automated technology employing a patented Enhanced ElectroChemiLuminescence (EECL) system for immunoassay analysis. In this innovative process, the signaling antibody (or antigen) is intricately labeled with an electronically Neutral Ruthenium Complex (NRC). Simultaneously, the capturing antibody (or antigen) is coated with magnetic microbeads.
Upon combining a clinical sample with the aforementioned antibodies (or antigen) and magnetic microbeads for a specific duration, a sandwich immunocomplex is meticulously formed on the microbeads’ surface. Subsequently, the microbeads are introduced into an ElectroChemiLuminescence measuring cell (a flow cell) and are precisely captured on the working electrode’s surface by a movable magnet located underneath.
- Real-Time Quantitative Thermal Cycler
The MA-6000 Real-Time Quantitative Thermal Cycler is poised to enhance patient care and reduce waiting times. This advanced system is capable of processing up to 96 samples simultaneously, offering a significant boost in efficiency. The Real-Time fluorescence quantitative PCR system, MA-6000, incorporates innovative hardware, a refined structure, and optimized software, ensuring the delivery of superior-quality results.
In each exhibit, Sansure invites attendees to embark on a journey through the pinnacle of diagnostic innovation, setting a new standard for excellence in the quest for accurate, efficient, and impactful healthcare solutions.
Sansure’s Commitment to an Infection-Free Future
Sansure’s commitment to diagnostic solutions extends far beyond product development. They are dedicated to fostering more innovative diagnostic solutions for an infection-free future. The group actively collaborates with healthcare professionals and researchers to drive further innovation.
Stay tuned with Sansure to see the potential of diagnostic solutions.